Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
21.72
+0.10 (0.45%)
Dec 4, 2025, 4:00 PM EST - Market closed
0.45% (1D)
| Assets | $14.90M |
| Expense Ratio | 0.55% |
| PE Ratio | 18.53 |
| Shares Out | 700,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 1,028 |
| Open | 21.58 |
| Previous Close | 21.62 |
| Day's Range | 21.58 - 21.72 |
| 52-Week Low | 15.37 |
| 52-Week High | 21.72 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
24.78% of assets| Name | Symbol | Weight |
|---|---|---|
| Teradata Corporation | TDC | 2.83% |
| Illumina, Inc. | ILMN | 2.53% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.51% |
| Lyft, Inc. | LYFT | 2.51% |
| UiPath Inc. | PATH | 2.51% |
| Biogen Inc. | BIIB | 2.43% |
| Jazz Pharmaceuticals plc | JAZZ | 2.42% |
| Expedia Group, Inc. | EXPE | 2.37% |
| Twilio Inc. | TWLO | 2.35% |
| United Therapeutics Corporation | UTHR | 2.31% |
